China partnerships drive biopharma’s biggest deal month since 2023
· amanda lanier
AI Briefing
- • Biopharma deal value reached $135.36 billion through first five months of 2026, surpassing previous years.
- • May 2026 was the year's biggest month at $41.78 billion in transactions.
- • May 2026 ranks third in recent years in terms of deal value, behind 2023 and 2022.
Context
Biopharma deal value has reached $135.36 billion through the first five months of 2026. May was the year's biggest month so far with $41.78 billion in transactions, far outpacing April's $13.87 billion.
The strong deal value in May and the year to date is significant as it outpaces every prior year, topping 2025's previous high of $103.92 billion, with May 2026 ranking as one of the strongest individual months on record.
Advertisement